New ways with old bones. Osteoporosis researchers look for drugs to replace hormone replacement therapy.
Bonn
Dot
D
D000975:Antioxidants / Q000627:therapeutic use; D001862:Bone Resorption / Q000503:physiopathology; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D000075202:Contraindications; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007529:Isoflavones / Q000627:therapeutic use; D020738:Leptin / Q000627:therapeutic use; D008562:Membrane Glycoproteins / Q000037:antagonists & inhibitors / Q000502:physiology; D010024:Osteoporosis / Q000188:drug therapy / Q000517:prevention & control*; D048789:Phytoestrogens; D028321:Plant Preparations / Q000627:therapeutic use; D053245:RANK Ligand; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D053246:Receptor Activator of Nuclear Factor-kappa B; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D019379:Teriparatide / Q000627:therapeutic use
D000975:Antioxidants; D002352:Carrier Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007529:Isoflavones; D020738:Leptin; D008562:Membrane Glycoproteins; D048789:Phytoestrogens; D028321:Plant Preparations; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D020845:Selective Estrogen Receptor Modulators; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D019379:Teriparatide; D020849:Raloxifene Hydrochloride